Oncology data solutions

We collect data from our comprehensive clinical test menu that provides a diverse population data set representative of the entire US population, including race, ethnicity, and rural and urban communities. We have over 2 million patient profiles from over 40,000 unique providers across 4,400 healthcare organizations. 

We tailor our data to your specific needs throughout the life cycle planning process. Our multi-modal test menu captures a wide variety of various cancer diagnoses and progression throughout the cancer care continuum. 

We are one of the largest oncology reference laboratories in the US, utilizing only NeoGenomics data. Our deep diagnostic and testing expertise allows us to focus on customized data solutions.

Other benefits to leveraging NeoGenomics data: 

• Custom use cases defined by your specific product goals and development timeline
• Agile delivery methods with collated and distributed data to fit your requirements
• High impact pre-launch planning, including forecasting, prevalence studies, and diagnostic landscape and testing trend analysis  
• Oncology and diagnostic expertise tailored to help with product development
• A true partnership in seeking the answers to cancer’s most pressing questions
• Data accuracy derived from an expansive portfolio of NeoGenomics-run oncology tests spanning multiple methodologies  

Review our variety of publications, poster presentations, and white papers.